Add Company
Join Now

Cadenza Bio Revenue and Competitors

License our Company Data API

USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Cadenza Bio's estimated annual revenue is currently $1.1M per year.(i)
  • Cadenza Bio's estimated revenue per employee is $155,000

Employee Data

  • Cadenza Bio has 7 Employees.(i)
  • Cadenza Bio grew their employee count by 17% last year.

Cadenza Bio's People

NameTitleEmail/Phone
1
Co-Founder & CEOReveal Email/Phone
2
COO, FounderReveal Email/Phone
3
Director, Research & DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$9.1M59-9%N/AN/A
#10
$16.6M1073%N/AN/A
Add Company

What Is Cadenza Bio?

Cadenza Bio, Inc. was founded in 2022 to accelerate and support the development of a series of novel, non-steroidal, highly selective compounds targeting Estrogen Receptor β (ERβ). Our patented and patent-pending compounds have shown therapeutic efficacy in preclinical animal models of Multiple Sclerosis and Endometriosis.\n\nOur goal goes beyond incremental improvements. We are dedicated to breaking the cycle of disease and, in doing so, transforming lives. We aim not only to alleviate symptoms but to halt progression, promote repair, and restore quality of life to enable total activity, empowering patients to regain control over their health.

keywords:N/A

N/A

Total Funding

7

Number of Employees

$1.1M

Revenue (est)

17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.1M70%$6.1M
#2
$3.5M7-30%N/A
#3
$0.5M7N/AN/A
#4
$0.9M7N/AN/A
#5
$0.5M7N/AN/A